Neurogene
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -854 | -787 | -17,241 | |
EBITDA | -32,110 | -30,080 | -23,947 | -20,176 |
EBIT | -34,488 | -30,934 | -24,734 | -20,952 |
Net Income | -34,488 | -30,934 | -24,735 | -20,953 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -24,115 | -26,400 | -16,787 | -19,808 |
Cash | 112,485 | 124,161 | 103,845 | 71,005 |
Basic Shares | 22,552 | 22,305 | 15,489 | 21,168 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $925 | $0 | $0 |
Gross Profit | -3,192 | -2,322 | -3,262 | -3,196 |
EBITDA | -87,254 | -71,885 | -33,008 | -51,991 |
EBIT | -90,346 | -75,132 | -36,305 | -55,187 |
Net Income | -90,351 | -75,144 | -36,317 | -55,189 |
Net Change In Cash | 0 | 925 | 0 | 0 |
Free Cash Flow | -78,356 | -71,411 | -51,743 | -55,054 |
Cash | 103,845 | 136,586 | 148,210 | 82,021 |
Basic Shares | 21,168 | 17,567 | 12,823 | 12,823 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.53 |
2026-03-31 | -$1.38 |
2025-12-31 | -$1.13 |
2025-09-30 | -$0.99 |